Nifty
Sensex
:
:
25776.00
83817.69
48.45 (0.19%)
78.56 (0.09%)

Pharmaceuticals & Drugs

Rating :
68/99

BSE: 524774 | NSE: NGLFINE

2164.20
04-Feb-2026
  • Open
  • High
  • Low
  • Previous Close
  •  2050
  •  2164.2
  •  2010
  •  1803.50
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  26212
  •  55906896.2
  •  2164.2
  •  957

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 1,351.91
  • 38.51
  • 5
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 1,432.76
  • 0.08%
  • 4.28

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 72.74%
  • 1.63%
  • 22.92%
  • FII
  • DII
  • Others
  • 0%
  • 0.00%
  • 2.71%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 14.07
  • 7.38
  • 9.81

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 1.92
  • -15.36
  • -0.09

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 4.75
  • -17.93
  • 1.00

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 31.86
  • 32.26
  • 37.23

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 5.35
  • 5.40
  • 4.20

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 19.18
  • 19.49
  • 21.07

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Dec 25
Dec 24
Var%
Sep 25
Sep 24
Var%
Jun 25
Jun 24
Var%
Mar 25
Mar 24
Var%
Net Sales
127.51
89.10
43.11%
120.26
93.48
28.65%
104.18
90.75
14.80%
94.97
99.76
-4.80%
Expenses
105.20
84.00
25.24%
103.10
81.93
25.84%
93.21
81.40
14.51%
88.65
83.94
5.61%
EBITDA
22.31
5.10
337.45%
17.16
11.56
48.44%
10.97
9.35
17.33%
6.32
15.82
-60.05%
EBIDTM
17.50%
5.72%
14.27%
12.36%
10.53%
10.30%
6.65%
15.86%
Other Income
4.61
-0.13
-
2.05
5.12
-59.96%
6.35
5.88
7.99%
-0.97
3.68
-
Interest
1.07
0.60
78.33%
1.16
0.32
262.50%
1.22
0.44
177.27%
0.97
0.49
97.96%
Depreciation
5.18
3.10
67.10%
5.08
3.03
67.66%
4.27
3.00
42.33%
3.32
2.92
13.70%
PBT
20.67
1.27
1,527.56%
12.96
13.33
-2.78%
11.84
11.79
0.42%
1.06
16.09
-93.41%
Tax
4.98
-0.01
-
3.34
3.52
-5.11%
2.60
2.57
1.17%
0.52
3.77
-86.21%
PAT
15.69
1.28
1,125.78%
9.63
9.81
-1.83%
9.24
9.22
0.22%
0.54
12.32
-95.62%
PATM
12.30%
1.43%
8.00%
10.50%
8.87%
10.16%
0.57%
12.35%
EPS
25.40
2.07
1,127.05%
15.58
15.88
-1.89%
14.96
14.92
0.27%
0.88
19.95
-95.59%

Annual Results

Standalone Figures in Rs. Crores /

Consolidated
Description
TTM
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Net Sales
446.92
368.26
338.69
278.08
317.50
257.97
151.69
153.17
Net Sales Growth
19.79%
8.73%
21.80%
-12.42%
23.08%
70.06%
-0.97%
 
Cost Of Goods Sold
216.47
182.40
158.68
140.32
146.99
102.34
64.36
62.63
Gross Profit
230.45
185.85
180.00
137.76
170.51
155.63
87.32
90.54
GP Margin
51.56%
50.47%
53.15%
49.54%
53.70%
60.33%
57.56%
59.11%
Total Expenditure
390.16
333.46
284.95
243.12
249.31
177.87
131.93
120.88
Power & Fuel Cost
-
26.03
23.25
18.53
16.29
10.15
10.30
9.02
% Of Sales
-
7.07%
6.86%
6.66%
5.13%
3.93%
6.79%
5.89%
Employee Cost
-
55.55
45.12
36.87
34.85
28.09
24.04
21.16
% Of Sales
-
15.08%
13.32%
13.26%
10.98%
10.89%
15.85%
13.81%
Manufacturing Exp.
-
40.24
31.41
24.14
28.94
18.22
17.22
13.21
% Of Sales
-
10.93%
9.27%
8.68%
9.11%
7.06%
11.35%
8.62%
General & Admin Exp.
-
12.34
10.55
8.79
6.23
5.11
6.11
5.33
% Of Sales
-
3.35%
3.11%
3.16%
1.96%
1.98%
4.03%
3.48%
Selling & Distn. Exp.
-
11.25
10.39
8.23
11.28
7.33
4.64
4.58
% Of Sales
-
3.05%
3.07%
2.96%
3.55%
2.84%
3.06%
2.99%
Miscellaneous Exp.
-
5.66
5.54
6.25
4.72
6.61
5.25
4.95
% Of Sales
-
1.54%
1.64%
2.25%
1.49%
2.56%
3.46%
3.23%
EBITDA
56.76
34.80
53.74
34.96
68.19
80.10
19.76
32.29
EBITDA Margin
12.70%
9.45%
15.87%
12.57%
21.48%
31.05%
13.03%
21.08%
Other Income
12.04
8.63
14.13
5.53
10.68
8.02
3.05
4.12
Interest
4.42
3.26
1.81
1.83
1.91
2.20
2.63
2.55
Depreciation
17.85
12.45
11.64
11.29
10.37
8.33
8.11
6.30
PBT
46.53
27.71
54.42
27.36
66.60
77.59
12.07
27.57
Tax
11.44
6.59
13.10
6.87
16.70
20.87
3.74
7.44
Tax Rate
24.59%
23.78%
24.07%
25.11%
25.08%
26.90%
30.99%
26.99%
PAT
35.10
21.12
41.32
20.50
49.90
56.72
8.34
20.13
PAT before Minority Interest
35.10
21.12
41.32
20.50
49.90
56.72
8.34
20.13
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
7.85%
5.74%
12.20%
7.37%
15.72%
21.99%
5.50%
13.14%
PAT Growth
7.57%
-48.89%
101.56%
-58.92%
-12.02%
580.10%
-58.57%
 
EPS
56.61
34.06
66.65
33.06
80.48
91.48
13.45
32.47

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Shareholder's Funds
282.43
262.63
222.55
203.22
154.46
98.96
92.12
Share Capital
3.09
3.09
3.09
3.09
3.09
3.09
3.09
Total Reserves
279.35
259.54
219.46
200.13
151.37
95.87
89.03
Non-Current Liabilities
31.99
6.32
6.24
8.06
11.16
11.62
11.90
Secured Loans
25.34
0.74
2.07
3.44
6.13
8.32
8.01
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
4.00
3.23
2.70
2.55
2.46
2.11
1.40
Current Liabilities
118.97
86.59
58.29
65.65
41.77
48.71
45.18
Trade Payables
57.52
49.39
24.59
37.16
29.53
20.83
16.12
Other Current Liabilities
12.15
3.97
3.67
4.44
6.12
6.34
5.61
Short Term Borrowings
47.82
31.70
28.41
23.43
4.83
14.60
15.31
Short Term Provisions
1.48
1.53
1.63
0.63
1.28
6.93
8.15
Total Liabilities
433.39
355.54
287.08
276.93
207.39
159.29
149.20
Net Block
142.67
85.57
87.91
88.77
64.13
67.74
60.94
Gross Block
217.03
148.11
139.39
129.53
95.96
91.81
74.07
Accumulated Depreciation
74.35
62.54
51.48
40.76
31.83
24.07
13.13
Non Current Assets
198.01
142.87
124.42
103.44
82.86
72.76
62.80
Capital Work in Progress
49.73
45.52
26.31
6.43
12.35
0.00
0.00
Non Current Investment
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Loans & Adv.
4.49
7.16
5.81
5.66
6.38
5.00
1.81
Other Non Current Assets
1.12
4.62
4.39
2.57
0.00
0.01
0.04
Current Assets
235.38
212.67
162.66
173.49
124.53
86.53
86.41
Current Investments
59.66
53.59
39.46
28.72
29.07
10.65
8.69
Inventories
51.27
43.30
26.99
56.01
37.85
27.90
18.61
Sundry Debtors
81.55
89.62
65.87
63.98
37.56
26.19
33.12
Cash & Bank
5.86
1.72
13.04
0.83
4.78
3.16
3.14
Other Current Assets
37.03
3.36
2.25
2.79
15.27
18.63
22.85
Short Term Loans & Adv.
32.55
21.07
15.04
21.17
13.97
12.17
15.61
Net Current Assets
116.41
126.08
104.36
107.84
82.76
37.82
41.23
Total Assets
433.39
355.54
287.08
276.93
207.39
159.29
149.21

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Cash From Operating Activity
35.82
20.47
35.29
13.82
27.35
20.46
8.85
PBT
27.71
54.42
27.36
66.60
77.59
12.07
27.57
Adjustment
13.71
11.76
11.53
11.33
4.73
12.16
7.87
Changes in Working Capital
0.98
-32.62
3.26
-47.40
-34.09
-0.03
-19.15
Cash after chg. in Working capital
42.41
33.57
42.15
30.52
48.22
24.20
16.29
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-6.59
-13.10
-6.87
-16.70
-20.87
-3.74
-7.44
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-34.55
-26.82
-27.02
-14.20
-24.57
-20.85
-9.54
Net Fixed Assets
-72.60
-27.42
-28.15
-12.77
-4.41
-7.18
Net Investments
-6.07
-14.13
-10.74
0.35
-18.42
-5.69
Others
44.12
14.73
11.87
-1.78
-1.74
-7.98
Cash from Financing Activity
-1.08
-1.08
-1.08
-1.08
-1.08
0.00
0.00
Net Cash Inflow / Outflow
0.19
-7.43
7.18
-1.46
1.70
-0.39
-0.70
Opening Cash & Equivalents
0.40
7.83
0.64
2.10
0.40
0.79
1.49
Closing Cash & Equivalent
0.58
0.40
7.83
0.64
2.10
0.40
0.79

Financial Ratios

Standalone /

Consolidated
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Book Value (Rs.)
457.16
425.11
360.23
328.94
250.01
160.18
149.11
ROA
5.36%
12.86%
7.27%
20.61%
31.42%
5.40%
13.49%
ROE
7.75%
17.03%
9.63%
27.90%
44.76%
8.72%
21.85%
ROCE
9.44%
20.38%
11.96%
33.91%
53.53%
11.93%
25.25%
Fixed Asset Turnover
2.02
2.36
2.07
2.82
2.75
1.83
2.07
Receivable days
84.83
83.78
85.22
58.36
45.10
71.37
78.93
Inventory Days
46.87
37.88
54.47
53.95
46.51
55.95
44.35
Payable days
106.96
85.07
75.67
72.38
78.66
47.96
48.15
Cash Conversion Cycle
24.74
36.59
64.02
39.93
12.95
79.36
75.13
Total Debt/Equity
0.27
0.13
0.15
0.15
0.11
0.29
0.29
Interest Cover
9.51
31.07
15.92
35.81
36.21
5.60
11.82

Top Investors:

News Update:


No Latest News!

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.